Videos
Latest Videos
Lantern Pharma Uses AI to Accelerate Cancer Drug Development | FintechTV Interview at the NYSE
Investors + biotech analysts: Lantern Pharma is pioneering AI-driven drug development — using large-scale machine learning to find new drugs, reposition existing molecules, and target precision oncology indications where unmet need is...
Floki Launches European ETP + TokenFi Expands Airdrop Automation with Nimbus | Tokenization Future
Investors + Web3 Builders: In this exclusive conversation, Floki’s Pedro Vidal reveals major new developments — including the launch of the Floki ETP in Europe and the rapid expansion of the TokenFi tokenization platform....
Investor Mega-Trends: AI Data Platforms, Brain Health & Music Royalties | Investor Event Special
For investors and market strategists — This New to The Street Investor Event Special highlights nine fast-growing plays across AI & automation data platforms, brain-health supplements/functional beverages, music royalties & live...
Ukrainian Folk Meets American Indie-Folk | Valeriia Vovk on Songwriting & Emotional Storytelling
For music lovers, indie-folk fans, and cultural arts enthusiasts — this New To The Street interview spotlights Valeriia Vovk, the Ukrainian-born singer/songwriter blending centuries-old Ukrainian folk tradition with contemporary American...
Turn Your Knowledge Into Online Income | Lisa Johnson on AI, Digital Courses & Financial Freedom
For entrepreneurs, moms, and anyone looking to make money online — this New to The Street interview features Lisa Johnson, the online business strategist who went from $45,000 in debt to earning over $30 million by helping people monetize...
Synergy CHC Expands Focus Factor Brand with Ready-to-Drink Beverages
For investors, health-conscious consumers, and retail industry followers — this NewsOut interview from the Nasdaq MarketSite features Jack Ross, CEO of Synergy CHC Corp (OTCQB: SNYR), discussing the company’s rapid growth and nationwide...
BioVie (NASDAQ: BIVI) Advances Parkinson’s & Long COVID Trials
For biotech investors, healthcare professionals, and science enthusiasts — this interview features Cuong Do, President & CEO of BioVie (NASDAQ: BIVI), providing an exciting update on the company’s clinical progress in Parkinson’s...
BioVie Advances Parkinson’s & Long COVID Trials | CEO Cuong Do & M&A Insights with Frank Aquila
For investors, biotech enthusiasts, and healthcare innovators — this New To The Street interview features Cuong Do, President & CEO of BioVie (NASDAQ: BIVI), and Frank Aquila, Senior M&A Partner at Sullivan & Cromwell, for a...
AI, Mega-Deals & the New M&A Landscape | Sullivan & Cromwell Partner Frank Aquila
For investors, dealmakers, and corporate strategists — this New To The Street interview features Frank Aquila, Senior M&A Partner at Sullivan & Cromwell, breaking down the latest global mergers and acquisitions trends shaping 2025...
